tiprankstipranks
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO

Aptevo Therapeutics (APVO) Financial Statements

321 Followers

Aptevo Therapeutics Financial Overview

Aptevo Therapeutics's market cap is currently ―. The company's EPS TTM is $-72.071; its P/E ratio is -0.06; Aptevo Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-11.59. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -6.20M$ -6.33M$ -7.95M$ 1.83M$ -5.16M
EBITDA$ -6.08M$ -6.21M$ -7.80M$ 2.00M$ -5.00M
Net Income Common Stockholders$ -5.90M$ -6.33M$ -7.95M$ 2.77M$ -4.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.90M$ 19.11M$ 21.01M$ 25.33M$ 22.64M
Total Assets$ 24.84M$ 27.13M$ 28.91M$ 34.97M$ 34.22M
Total Debt$ 5.40M$ 5.60M$ 5.70M$ 5.90M$ 9.56M
Net Debt$ -11.50M$ -13.51M$ -15.31M$ -19.43M$ -13.08M
Total Liabilities$ 12.62M$ 12.41M$ 12.61M$ 11.71M$ 16.24M
Stockholders Equity$ 12.22M$ 14.72M$ 16.25M$ 23.26M$ 17.97M
Cash Flow-
Free Cash Flow$ -5.25M$ -6.24M$ -4.80M$ 4.57M$ -5.94M
Operating Cash Flow$ -5.25M$ -6.24M$ -4.80M$ 4.57M$ -5.94M
Investing Cash Flow-----
Financing Cash Flow$ 3.05M$ 4.34M$ 481.00K$ -1.87M$ 6.00M
Currency in USD

Aptevo Therapeutics Earnings and Revenue History

Aptevo Therapeutics Debt to Assets

Aptevo Therapeutics Cash Flow

Aptevo Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis